The results suggest that DOC, but not SOX, activity measurements can provide informative value as an additional biomarker for CLD that can become complementary to ALT determinations, especially in patients displaying low ALT values in spite of ongoing disease. The gene discussed is GPT; the disease is congenital secretory chloride diarrhea 1.